Friday, April 26, 2019
8:00 am - 5:00 pm
Oregon AHEC invites practicing health professionals, health care administrators, health profession students, and all those interested to attend the first Oregon AHEC Opioid Symposium. The audience will hear about the importance of opioid use disorder recognition and treatment, as well as what kinds of opioid treatment programs are available in rural and underserved settings and furthering their knowledge regarding opioid use disorder.
Locations, details, and agenda: www.ohsu.edu/opioidsymposium
Registration is required: www.oshu.edu/opioidsymposiumregister
General Attendance is FREE. The fee for the CME Credit is $25 payable via the registration link.
Each speaker will start at the top of the hour. Feel free to stop by for some all of the presentations.
ATTENTION: All Oregon-licensed physicians and PAs who have a DEA number are required to register for the Prescription Drug Monitoring Program (PDMP) by July 1, 2018. Register at https://oregon.pmpaware.net by selecting "Create an Account." For more information, please review OAR 333-023-0825 or contact the PDMP at 866-205-1222 or email@example.com.
The Oregon Pain Guidance website provides pain management guidance and tools for healthcare professionals as well as patients and families.
Note: The National Transportation Safety Board reminds health care providers to discuss with patients the effects that their medical conditions and medications may have on their ability to safely operate a vehicle in any mode of transportation.
Medication Assisted Treatment (MAT) for Opioid Addiction – Physician Assistants and Nurse Practitioners are now included among the healthcare professionals who may provide MAT for opioid addiction. More information is available on the Substance Abuse and Mental Health Services Administration (SAMHSA) website. All MAT providers must complete training and be granted a waiver by the DEA. The required 24-hour continuing education training is free and available through the Providers' Clinical Support System.
SAMHSA began certifying PAs and NPs on February 21, 2017. As of August 28, 2018, there were 687 certified PAs nationwide and 2,471 certified NPs. SAMHSA says, "More buprenorphine prescribers are needed to combat the opioid crisis and treat substance use disorders, particularly in rural areas."